Study ID: TV5600-CNS-20007 | 2014-000418-75
Study Title
- A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod
Teva Identifier
- TV5600-CNS-20007 | 2014-000418-75
ClinicalTrials.gov Identifier
- NCT02215616
Study Status
- Completed
Trial Condition(s)
- Huntington's Disease
Interventions
- Drug: Laquinimod | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 21 Years to 55 Years
Trial Duration
- October 28, 2014 - June 19, 2018
Phase
- Phase 2
Study Type
Interventional